市場調査レポート

商品コード

1562494

尿検査の市場規模、シェア、成長分析、製品タイプ別、用途別、地域別 - 産業予測、2024年～2031年

Urinalysis Market Size, Share, Growth Analysis, By Product, By Test Type, By Application, By Region - Industry Forecast 2024-2031

出版日: 2024年09月14日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

尿検査の世界市場規模は、2022年に39億米ドルと評価され、2023年の42億8,000万米ドルから2031年には89億7,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは9.70％で成長する見通しです。

世界の尿検査市場はヘルスケア分野で急速に拡大しています。尿検査、すなわち尿検査では、尿サンプルを分析してさまざまな病状を診断し、一般的な健康状態をモニターします。この診断ツールは疾病の早期発見と管理に極めて重要であり、世界中のヘルスケア現場での定番となっています。技術や検査方法の進歩により、尿検査の精度、効率、信頼性が大幅に向上し、病院、診療所、診断ラボ、在宅医療環境での利用が増加しています。尿検査市場の成長を後押ししている要因はいくつかあります。尿路感染症、腎臓病、その他の泌尿器系疾患の発生率の上昇は主要な促進要因です。さらに、高齢者人口の増加と糖尿病や高血圧などの慢性疾患の有病率の増加が、ルーチン尿検査の需要を高めています。また、従来の手動検査から自動化されたポイントオブケア（POC）システムへの移行により、検査のスピードと利便性が向上し、医療従事者がタイムリーに十分な情報に基づいた判断を下せるようになっています。市場は競争が激しく、多くの企業が研究開発に投資して革新的な製品や技術を導入しています。主要企業は、市場での存在感と競争力を高めるため、製品の発売、合併、買収、提携、戦略的パートナーシップを推進しています。全体として、世界の尿検査市場は、技術の進歩や疾病の早期発見と継続的な健康モニタリングのニーズの高まりによって、継続的な成長が見込まれています。

市場概要
消耗品
- 妊娠・不妊治療キット
- ディップスティック
- 試薬
- 使い捨て
機器
- 自動尿分析装置
- 統合尿分析装置
- 尿沈渣分析装置
- フローサイトメトリー分析装置
- 顕微鏡分析装置
- 生化学尿分析装置
- 半自動尿分析装置
- ポイントオブケア尿分析装置

尿検査市場：検査タイプ別

市場概要
妊娠と不妊検査
生化学検査
- 臨床検査
- POC検査
堆積物尿検査

尿検査市場：用途別

市場概要
病気のスクリーニング
- 尿路感染症
- 腎臓疾患
- 糖尿病
- 肝臓疾患
- その他
妊娠と不妊検査

尿検査市場：エンドユーザー別

市場概要
診断検査室
病院・クリニック
在宅ケア環境
研究ラボ・研究機関

尿検査市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche Ltd.（Switzerland）
Cardinal Health（US）
Danaher（US）
Abbott（US）
Sysmex Corporation（Japan）
Thermo Fisher Scientific Inc.（US）
QuidelOrtho Corporation（US）
Becton, Dickinson and Company（US）
Bio-Rad Laboratories, Inc.（US）
EKF Diagnostics Holdings PLC（UK）
Arkray, Inc.（Japan）
ACON Laboratories, Inc.（US）
77 Elektronika Kft.（Hungary）
URIT Medical Electronic Co., Ltd.（China）
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（China）
Dirui Industrial Co., Ltd.（China）
BIOBASE Group（China）
Erba Mannheim（Germany）
Alphatec Scientific E.I.R.L.（Peru）
Teco Diagnostics（US）
Analyticon Biotechnologies GmbH（Germany）
Bioway Biological Technology Co., Ltd.（China）
High Technology, Inc.（US）
Agappe Diagnostics Ltd（India）
Toyobo Co., Ltd.（Japan）
DIALAB GmbH（Austria）
Quantimetrix（US）
Biocare Corporation（Taiwan）
Randox Laboratories Ltd.（UK）
PZ Cormay S.A.（Poland）
YD Diagnostics（South Korea）
Contec Medical Systems Co., Ltd.（China）
Biopanda Reagents Ltd.（UK）

Product Code: SQMIG35A2632

Global Urinalysis Market size was valued at USD 3.9 billion in 2022 and is poised to grow from USD 4.28 billion in 2023 to USD 8.97 billion by 2031, growing at a CAGR of 9.70% during the forecast period (2024-2031).

The global urinalysis market is rapidly expanding within the healthcare sector. Urinalysis, or urine testing, involves analyzing urine samples to diagnose various medical conditions and monitor general health. This diagnostic tool is crucial for the early detection and management of diseases, making it a staple in healthcare settings worldwide. Advances in technology and testing methods have significantly enhanced the accuracy, efficiency, and reliability of urinalysis, leading to its increased use in hospitals, clinics, diagnostic labs, and homecare environments. Several factors are fueling the growth of the urinalysis market. The rising incidence of urinary tract infections, kidney diseases, and other urological disorders is a major driver. Additionally, the growing elderly population and the higher prevalence of chronic conditions like diabetes and hypertension have increased the demand for routine urine testing. The transition from traditional manual testing to automated and point-of-care urinalysis systems has also improved the speed and convenience of testing, allowing healthcare professionals to make timely and informed decisions. The market is highly competitive, with many companies investing in research and development to introduce innovative products and technologies. Key players are pursuing product launches, mergers, acquisitions, collaborations, and strategic partnerships to enhance their market presence and competitive edge. Overall, the global urinalysis market is poised for continued growth, driven by technological advancements and the increasing need for early disease detection and ongoing health monitoring.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinalysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Urinalysis Market Segmental Analysis

Global Urinalysis Market is segmented by Product, Test Type, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Test Type, the market is segmented into Pregnancy & Fertility Tests, Biochemical Tests, and Sediment Urinalysis. Based on Application, the market is segmented into Disease Screening, and Pregnancy & Fertility Testing. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Urinalysis Market

A key driver of market growth is the increasing incidence of urinary tract infections (UTIs) in developing countries. This rising prevalence significantly impacts the market, as untreated UTIs can progress to affect the kidneys and lead to complications during pregnancy. The market's expansion is largely fueled by the potential severity of UTIs if left untreated. Complications such as kidney infections and adverse effects on pregnant women underscore the urgent need for effective diagnostic and treatment solutions, further propelling market development.

Restraints in the Global Urinalysis Market

The availability of reconditioned urine analyzers is expected to limit the market's growth during the forecast period. These devices, while cost-effective, may impact the demand for new, advanced analyzers, thereby constraining market expansion. Additionally, potential changes in regulatory environments could further challenge the growth of the urinalysis industry. Stricter regulations or altered oversight requirements might complicate market conditions and hinder future development.

Market Trends of the Global Urinalysis Market

The demand for point-of-care urinalysis testing is increasing, driven by its ability to deliver rapid, on-site diagnoses. This approach allows healthcare professionals to obtain immediate results, which supports quicker decision-making and enhances patient outcomes. Point-of-care testing is valued for its efficiency and convenience, offering real-time data that helps streamline clinical processes and improve overall patient care. The ability to conduct tests and receive results on the spot is becoming increasingly important in various healthcare settings.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Urinalysis Market by Product

Market Overview
Consumables
- Pregnancy & Fertility Kits
- Dipsticks
- Reagents
- Disposables
Instruments
- Automated Urine Analyzers
- Integrated urine analyzers
- Sediment urine analyzers
- Flow cytometry analyzers
- Microscopy analyzers
- Biochemical urine analyzers
- Semi-automated Urine Analyzers
- Point-of-care Urine Analyzers

Urinalysis Market by Test Type

Market Overview
Pregnancy & Fertility Tests
Biochemical Tests
- Laboratory Tests
- POC Tests
Sediment Urinalysis

Urinalysis Market by Application

Market Overview
Disease Screening
- Urinary Tract Infections
- Kidney Diseases
- Diabetes
- Liver Diseases
- Others
Pregnancy & Fertility Testing

Urinalysis Market by End User

Market Overview
Diagnostic Laboratories
Hospitals & Clinics
Home Care Settings
Research Laboratories & Institutes

Urinalysis Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuidelOrtho Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EKF Diagnostics Holdings PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arkray, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
77 Elektronika Kft. (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
URIT Medical Electronic Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dirui Industrial Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOBASE Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Erba Mannheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alphatec Scientific E.I.R.L. (Peru)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teco Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Analyticon Biotechnologies GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioway Biological Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
High Technology, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agappe Diagnostics Ltd (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toyobo Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DIALAB GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quantimetrix (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocare Corporation (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PZ Cormay S.A. (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
YD Diagnostics (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Contec Medical Systems Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biopanda Reagents Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments